E. Long, REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS, Annual Review of Immunology, vol.17, issue.1, pp.875-904, 1999.
DOI : 10.1146/annurev.immunol.17.1.875

T. Bellon, F. Kitzig, J. Sayos, and M. Lopez-botet, Mutational Analysis of Immunoreceptor Tyrosine-Based Inhibition Motifs of the Ig-Like Transcript 2 (CD85j) Leukocyte Receptor, The Journal of Immunology, vol.168, issue.7, pp.3351-3359, 2002.
DOI : 10.4049/jimmunol.168.7.3351

D. Saverino, M. Fabbi, F. Ghiotto, A. Merlo, S. Bruno et al., The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions, The Journal of Immunology, vol.165, issue.7, pp.3742-3755, 2000.
DOI : 10.4049/jimmunol.165.7.3742

D. Cosman, N. Fanger, L. Borges, M. Kubin, W. Chin et al., A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules, Immunity, vol.7, issue.2, pp.273-282, 1997.
DOI : 10.1016/S1074-7613(00)80529-4

M. Colonna, F. Navarro, T. Bellon, M. Llano, P. Garcia et al., A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells, The Journal of Experimental Medicine, vol.138, issue.11, pp.1809-1818, 1997.
DOI : 10.1038/321700a0

L. Berg, G. Riise, D. Cosman, T. Bergstrom, S. Olofsson et al., LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients, The Lancet, vol.361, issue.9363, pp.1099-1101, 2003.
DOI : 10.1016/S0140-6736(03)12855-3

K. Kuroki, N. Tsuchiya, M. Shiroishi, L. Rasubala, Y. Yamashita et al., Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis, Human Molecular Genetics, vol.14, issue.16, pp.2469-2480, 2005.
DOI : 10.1093/hmg/ddi247

A. Monsivais-urenda, P. Nino-moreno, C. Abud-mendoza, L. Baranda, E. Layseca-espinosa et al., Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE), Journal of Autoimmunity, vol.29, issue.2-3, pp.97-105, 2007.
DOI : 10.1016/j.jaut.2007.05.003

J. Dietrich, M. Cella, and M. Colonna, Ig-Like Transcript 2 (ILT2)/Leukocyte Ig-Like Receptor 1 (LIR1) Inhibits TCR Signaling and Actin Cytoskeleton Reorganization, The Journal of Immunology, vol.166, issue.4, pp.2514-2521, 2001.
DOI : 10.4049/jimmunol.166.4.2514

E. Morel and T. Bellon, HLA Class I Molecules Regulate IFN-?? Production Induced in NK Cells by Target Cells, Viral Products, or Immature Dendritic Cells through the Inhibitory Receptor ILT2/CD85j, The Journal of Immunology, vol.181, issue.4, pp.2368-2381, 2008.
DOI : 10.4049/jimmunol.181.4.2368

D. Saverino, A. Merlo, S. Bruno, V. Pistoia, C. Grossi et al., Dual Effect of CD85/Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2 and CD152 (CTLA-4) on Cytokine Production by Antigen-Stimulated Human T Cells, The Journal of Immunology, vol.168, issue.1, pp.207-215, 2002.
DOI : 10.4049/jimmunol.168.1.207

C. Tenca, A. Merlo, E. Merck, E. Bates, D. Saverino et al., CD85j (Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2) Inhibits Human Osteoclast-Associated Receptor-Mediated Activation of Human Dendritic Cells, The Journal of Immunology, vol.174, issue.11, pp.6757-6763, 2005.
DOI : 10.4049/jimmunol.174.11.6757

E. Lesport, J. Baudhuin, S. Sousa, J. Lemaoult, A. Zamborlini et al., Inhibition of human V??9V??2 T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer, Cellular and Molecular Life Sciences, vol.72, issue.20, pp.3385-3399, 2011.
DOI : 10.1007/s00018-011-0632-7

N. Young, E. Waller, R. Patel, A. Roghanian, J. Austyn et al., The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells, Blood, vol.111, issue.6, pp.3090-3096, 2008.
DOI : 10.1182/blood-2007-05-089771

J. Kim, S. Choi, I. Yun, J. Kim, C. Ahn et al., Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis, Biochemical and Biophysical Research Communications, vol.315, issue.1, pp.144-150, 2004.
DOI : 10.1016/j.bbrc.2004.01.027

H. Reyburn, O. Mandelboim, M. Vales-gomez, D. Davis, L. Pazmany et al., The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells, Nature, vol.386, issue.6624, pp.514-517, 1997.
DOI : 10.1038/386514a0

C. Leong, T. Chapman, P. Bjorkman, D. Formankova, E. Mocarski et al., Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog, The Journal of Experimental Medicine, vol.151, issue.10, pp.1681-1687, 1998.
DOI : 10.1016/S0092-8674(01)80014-3

D. Saverino, F. Ghiotto, A. Merlo, S. Bruno, L. Battini et al., Specific Recognition of the Viral Protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T Cells Mediates the Non-MHC-Restricted Lysis of Human Cytomegalovirus-Infected Cells, The Journal of Immunology, vol.172, issue.9, pp.5629-5637, 2004.
DOI : 10.4049/jimmunol.172.9.5629

C. Wagner, G. Riise, T. Bergstrom, K. Karre, E. Carbone et al., Increased Expression of Leukocyte Ig-Like Receptor-1 and Activating Role of UL18 in the Response to Cytomegalovirus Infection, The Journal of Immunology, vol.178, issue.6, pp.3536-3543, 2007.
DOI : 10.4049/jimmunol.178.6.3536

D. Scott-algara, V. Arnold, C. Didier, T. Kattan, G. Pirozzi et al., The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells, PLoS ONE, vol.77, issue.4, p.1975, 2008.
DOI : 10.1371/journal.pone.0001975.g006

C. Urbinati, S. Nicoli, M. Giacca, G. David, S. Fiorentini et al., HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium, Blood, vol.114, issue.15, pp.3335-3342, 2009.
DOI : 10.1182/blood-2009-01-198945

C. Perera, H. Mcneil, and C. Geczy, S100 Calgranulins in inflammatory arthritis, Immunology and Cell Biology, vol.64, issue.1, pp.41-49, 2010.
DOI : 10.1016/S0531-5565(00)00118-2

C. Li, B. Houser, M. Nicotra, and J. Strominger, HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells, Proceedings of the National Academy of Sciences, vol.106, issue.14, pp.5767-5772, 2009.
DOI : 10.1073/pnas.0901173106

L. Fadda, G. Borhis, P. Ahmed, K. Cheent, S. Pageon et al., Peptide antagonism as a mechanism for NK cell activation, Proceedings of the National Academy of Sciences, vol.107, issue.22, pp.10160-10165, 2010.
DOI : 10.1073/pnas.0913745107

C. Gebhardt, A. Riehl, M. Durchdewald, J. Nemeth, G. Furstenberger et al., RAGE signaling sustains inflammation and promotes tumor development, The Journal of Experimental Medicine, vol.167, issue.2, pp.275-285, 2008.
DOI : 10.1158/0008-5472.CAN-06-3798

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271015

J. Ehrchen, C. Sunderkotter, D. Foell, T. Vogl, and R. J. , The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer, Journal of Leukocyte Biology, vol.86, issue.3, pp.557-566, 2009.
DOI : 10.1189/jlb.1008647

M. Goebeler, J. Roth, F. Burwinkel, E. Vollmer, W. Bocker et al., EXPRESSION AND COMPLEX FORMATION OF S100-LIKE PROTEINS MRP8 AND MRP14 BY MACROPHAGES DURING RENAL ALLOGRAFT REJECTION, Transplantation, vol.58, issue.3, pp.355-361, 1994.
DOI : 10.1097/00007890-199408000-00018

J. Rugtveit, P. Brandtzaeg, T. Halstensen, O. Fausa, and H. Scott, Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes., Gut, vol.35, issue.5, pp.669-674, 1994.
DOI : 10.1136/gut.35.5.669

G. Zwadlo, J. Bruggen, G. Gerhards, R. Schlegel, and C. Sorg, Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues, Clin Exp Immunol, vol.72, pp.510-515, 1988.

G. Cohen, R. Gandhi, D. Davis, O. Mandelboim, B. Chen et al., The Selective Downregulation of Class I Major Histocompatibility Complex Proteins by HIV-1 Protects HIV-Infected Cells from NK Cells, Immunity, vol.10, issue.6, pp.661-671, 1999.
DOI : 10.1016/S1074-7613(00)80065-5

K. Collins and D. Baltimore, HIV's evasion of the cellular immune response, Immunological Reviews, vol.90, issue.1, pp.65-74, 1999.
DOI : 10.1126/science.278.5342.1447

P. Cheng, C. Corzo, N. Luetteke, Y. B. Nagaraj, S. Bui et al., Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein, The Journal of Experimental Medicine, vol.94, issue.10, pp.2235-2249, 2008.
DOI : 10.2527/jas.2005-766

G. Alter, J. Malenfant, and M. Altfeld, CD107a as a functional marker for the identification of natural killer cell activity, Journal of Immunological Methods, vol.294, issue.1-2, pp.15-22, 2004.
DOI : 10.1016/j.jim.2004.08.008

V. Piguet, O. Schwartz, L. Gall, S. Trono, and D. , The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors, Immunological Reviews, vol.271, issue.1, pp.51-63, 1999.
DOI : 10.1083/jcb.136.4.811

URL : https://hal.archives-ouvertes.fr/pasteur-01372749

. Arnold, S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells, Retrovirology, vol.10, issue.1, p.122, 2013.
DOI : 10.1111/j.1600-065X.1999.tb01282.x

URL : https://hal.archives-ouvertes.fr/inserm-00904109